QuantHealth Raises $45 Million to Expand AI Clinical-Trial Simulations

Israeli clinical-trial simulation company QuantHealth raised $45 million in a Series B round led by Qumra Capital, bringing its total funding to $75 million. Pitango HealthTech, Sanofi Ventures and six other investors participated. QuantHealth says the capital will expand enterprise deployment of its AI platform, which tests clinical and commercial decisions before patients are enrolled or capital is committed. The company says it has simulated more than 600 trials across 30 indications with predictive accuracy of up to 90%, and plans to expand beyond 40 indications in oncology, cardiometabolic disease and inflammation.